1. Home
  2. PTY vs TWST Comparison

PTY vs TWST Comparison

Compare PTY & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTY
  • TWST
  • Stock Information
  • Founded
  • PTY 2002
  • TWST 2013
  • Country
  • PTY United States
  • TWST United States
  • Employees
  • PTY N/A
  • TWST N/A
  • Industry
  • PTY Investment Managers
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PTY Finance
  • TWST Health Care
  • Exchange
  • PTY Nasdaq
  • TWST Nasdaq
  • Market Cap
  • PTY 2.2B
  • TWST 2.6B
  • IPO Year
  • PTY N/A
  • TWST 2018
  • Fundamental
  • Price
  • PTY $14.46
  • TWST $39.26
  • Analyst Decision
  • PTY
  • TWST Buy
  • Analyst Count
  • PTY 0
  • TWST 10
  • Target Price
  • PTY N/A
  • TWST $52.50
  • AVG Volume (30 Days)
  • PTY 550.4K
  • TWST 1.1M
  • Earning Date
  • PTY 01-01-0001
  • TWST 05-01-2025
  • Dividend Yield
  • PTY 9.65%
  • TWST N/A
  • EPS Growth
  • PTY N/A
  • TWST N/A
  • EPS
  • PTY N/A
  • TWST N/A
  • Revenue
  • PTY N/A
  • TWST $330,189,000.00
  • Revenue This Year
  • PTY N/A
  • TWST $22.62
  • Revenue Next Year
  • PTY N/A
  • TWST $17.76
  • P/E Ratio
  • PTY N/A
  • TWST N/A
  • Revenue Growth
  • PTY N/A
  • TWST 25.85
  • 52 Week Low
  • PTY $11.92
  • TWST $27.41
  • 52 Week High
  • PTY $14.88
  • TWST $60.90
  • Technical
  • Relative Strength Index (RSI)
  • PTY 47.82
  • TWST 41.99
  • Support Level
  • PTY $14.30
  • TWST $40.50
  • Resistance Level
  • PTY $14.42
  • TWST $44.94
  • Average True Range (ATR)
  • PTY 0.07
  • TWST 2.38
  • MACD
  • PTY 0.02
  • TWST 0.17
  • Stochastic Oscillator
  • PTY 81.56
  • TWST 26.32

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: